We talked to two experts who help children who may be immunocompromised following cancer treatments sort through the risks and benefits of deciding when it’s safe to return to school. Media contact: Claire Hudson, Returning to school, post-transplantĪs schools reopen for in-person learning, families weigh the risks of exposure to infectious diseases. Beyond studying the effectiveness of antivirals and monoclonal antibodies, researchers are looking at practical matters, such as comparing intravenous drip and injections for delivery. Get the latest insights on COVID-19 therapies from researchers at the Hutch’s COVID-19 Clinical Research Center. Ongoing trials test COVID-19 drugs for earlier, easier treatment Thomas Lynch Jr., Nancy Davidson, McGarry Houghton, Nina Salama and Joshua Schiffer. Join us for our next public science event, “ Finding New Ways to Stop Solid Tumors.” The virtual discussion will be 11 a.m. 5, 2021 - Below are summaries of recent Fred Hutch research findings and other news. Diversity, Equity and Reduction of Health Disparities.Immunotherapy, Data Science, and the Steam Plant.Institutional Partners & Collaborations.Vaccine and Infectious Disease Division.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |